SMPD1 and anterior segment dysgenesis: In certain cases, reduced or absent enzyme activity is subsequently confirmed through molecular genetic testing, which identifies pathogenic variants in the SMPD1 gene, thereby establishing a definitive diagnosis of ASMD (11).